Switching From Methadone to Diamorphine—2-Year Results of the German Heroin-Assisted Treatment Trial

REFERENCES

• Blanken, P., Hendriks, V. M., Van Den Brink, W., & van Ree, J. M. (2005). Heroin auf rezept für die behandlung von therapieresistenten chronisch heroinabhängigen. Die resultate niederländischer studien und der aktuelle stand [Medical prescription of heroin to treatment resistant chronic heroin addicts. Results of the Dutch studies and state of affairs]. Konturen, 26(6), 18–21.
   Google Scholar
• Central Committee on the Treatment of Heroin Addicts. (2002). Medical co-prescription heroin. Two randomized controlled trials. Utrecht: Author.
   Google Scholar
• Darke, S., Ward, J., Zador, D., & Swift, G. (1991). A scale for estimating the health status of opioid users. British Journal of Addiction, 86, 1317–1322.
   PubMedGoogle Scholar
• Degkwitz, P., Lichtermann, D., Deibler, P., Soyka, M., Schneider, U., Dieninghoff, D., (2007). “Schwerstabhängige”—Die teilnehmer des modellprojekts zur heroingestützten behandlung [“Heavy injection drug users”—The participants of the trial on heroin-based treatment]. Suchttherapie, 8, 12–18.
   Google Scholar
• Derogatis, L. R. (1983). SCL-90-R: Administration, scoring and procedures. Manual II. Towsen, MD: Clinical Psychometric Research.
   Google Scholar
• Farnbacher, G., Brückner, E., & Haasen, C. (2008). Manual zur psychoedukation opiatabhängiger menschen [Manual of psycho-educative group therapy for opiate dependent persons]. Freiburg, Germany: Lambertus.
   Google Scholar
• Fischer, B., Oviedo-Joeckes, E., Blanken, P., Haasen, C., Rehm, J. Schechter, M. T., (2007). Heroin-assisted treatment (HAT) a decade later: A brief update on science and politics. Journal of Urban Health, 84, 552–562.
   PubMed Web of Science ®Google Scholar
• Gsellhofer, B., Küfner, H., Vogt, M., & Weiler, D. (1999). European addiction severity index EuropASI. Nach der 5. Auflage der amerikanischen version von McLellan und der Europäischen version des ASI. Baltmannsweiler, Germany: Schneider Verlag Hohengehren.
   Google Scholar
• Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2002). Die lebenssituation von drogenabhängigen der heroin gestützten behandlung in der Schweiz—Eine 6-jahres-katamnese [The social situation of patients and ex-patients of heroin-assisted treatment in Switzerland—A six year follow-up study]. Sucht, 48, 370–378.
   Google Scholar
• Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2003). Evaluating long-term effects of heroin-assisted treatment—The results of a 6-year follow-up. European Addiction Research, 9, 73–79.
   PubMed Web of Science ®Google Scholar
• Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence. Randomised controlled trial. British Journal of Psychiatry, 191, 55–62.
   PubMed Web of Science ®Google Scholar
• Hartnoll, R. L., Mitcheson, M. C., Battersby, A., Brown, G., Ellis, M., Fleming, P., (1980). Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry, 37, 877– 884.
   PubMed Web of Science ®Google Scholar
• Koeter, M. W. J., & Hartgers, C. (1997). European addiction severity index EuropASI. Cost A6. Preliminary procedure for the computation of the EuropASI composite scores. Amsterdam: The Amsterdam Institute for Addiction Research.
   Google Scholar
• Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1, 208– 210.
   Google Scholar
• Kuhn, S., Farnbacher, G., Verthein, U., Krausz, M., & Haasen, C. (2007). Das psychoedukative Gruppenprogramm in der bundesdeutschen Heroinstudie—Eine innovative Behandlungsmethode [Psychoeducation within the German heroin trial—An innovative treatment approach]. Suchttherapie, 8, 26–32.
   Google Scholar
• Lintzeris, N., Strang, J., Metrebian, N., Byford, S., Hallam, C., Lee, S., (2006). Methodology for the randomised injecting opioid treatment trial (RIOTT): Evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduction Journal, 3, 28–40.
   PubMedGoogle Scholar
• Löbmann, R., & Verthein, U. (2009). Explaining the effectiveness of medical treatment for heroin addicts on crime reductions. Law and Human Behavior, 33, 83–95.
   Google Scholar
• March, J. C., Oviedo-Joekes, E., Perea-Milla, E., Carrasco, F., & the PEPSA Team. (2006). Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of Substance Abuse Treatment, 31, 203–211.
   PubMed Web of Science ®Google Scholar
• Metrebian, N., Shanahan, W., Wells, B., & Stimson, G. V. (1998). Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions. The Medical Journal of Australia, 168, 596–600.
   PubMed Web of Science ®Google Scholar
• NAOMI Study Team. (2008). Reaching the hardest to reach—Treating the hardest-to-treat. Summary of the primary outcomes of the North American Opiate Medication Initiative (NAOMI). Vancouver, BC: Author.
   Google Scholar
• Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., (2009). Diacetylmorphine versus methadone for the treatment of opioid addiction. New England Journal of Medicine, 361, 777–786.
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes, E., Nosyk, B., Brissette, S., Chettiar, J., Schneeberger, P., Marsh, D. C., (2008). The North American Opiate Medication Initiative (NAOMI): Profile of participants in North America's first trial of heroin-assisted treatment. Journal of Urban Health, 85, 812–825.
   PubMed Web of Science ®Google Scholar
• Perneger, T. V., Giner, F., del Rio, M., & Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13–18.
   PubMed Web of Science ®Google Scholar
• Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2001). Feasibility, saftey, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet, 358, 1417–1423.
   PubMed Web of Science ®Google Scholar
• Ribeaud, D. (2005). Gibt es einen Delinquenzrückgang durch soziale Reintegration im Rahmen der schweizerischen Heroinverschreibungsversuche? [Is there a reduction in crime through social reintegration in the context of the Swiss heroin trials?]. Sucht, 51, 76–87.
   Google Scholar
• Uchtenhagen, A., Dobler-Mikola, A., Steffen, T., Gutzwiller, F., Blättler, R., & Pfeifer, S. (1999). Prescription of narcotics for heroin addicts. Basel, Switzerland: Karger.
   Google Scholar
• van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W. J., van Zwieten, B. J., & van Ree, J. M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal, 327, 310–315.
   PubMed Web of Science ®Google Scholar
• van den Brink, W., Hendriks, V. M., & van Ree, J. M. (1999). Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands. Journal of Drug Issues, 29, 587–607.
   Web of Science ®Google Scholar
• Verthein, U., Bonorden-Kleij, K., Degkwitz, P., Dilg, C., Köhler, W. K., Passie, T., (2008). Long-term effects of heroin-assisted treatment in Germany. Addiction, 103, 960–966.
   PubMed Web of Science ®Google Scholar
• Ville de Liège—Coordination des Actions en Toxicomanie. (2007). Héroïne à usage médical. Projet pilote de traitement assisté pardiacétylmorphine. Liège: Author.
   Google Scholar
• Vogt, I., Schmid, M., Schu, M., Simmedinger, R., & Schlanstedt, G. (2007). Motivierendes Case Management (MOCA) in der deutschen Studie zur heroin-gestützten behandlung von opiatabhängigen [Motivational case management in the German study on heroin-supported treatment of opiate dependents]. Suchttherapie, 8, 19–25.
   Web of Science ®Google Scholar